… This study evaluated the serologic response to a third BNT162b2 mRNA vaccine dose in
patients with CLL/SLL who had failed to respond to the standard 2-dose vaccination program. …

… patients who completed their treatment and remained in response at the time of vaccination
… Our results also suggest that a second timely vaccine dose is necessary for patients with …

… vaccine dose was evident in 55% of patients with CLL and 100% in age matched controls.
Titers increased by 10-fold in patients with CLL… after previous vaccinations, neutralizing assay, …

… to vaccination strategies in patients with hematologic malignancy, including those with CLL,
… Previous reports suggesting poor immunogenicity among patients with CLL receiving SD …

… We examined 44 consecutive patients with CLL who received two doses of mRNA vaccine
(… and laboratory parameters prior to first dose of COVID-19 vaccine were collected. Logistic …

… Pooled seropositivity rates were 51% in 1446 patients with CLL after 2 doses of the vaccine
[… rate after two doses of the COVID-19 vaccines was in the CLL population [Citation72]. Most …

… two patients received five doses of vaccines whereas the next ten patients received eight
doses of vaccines… Minor decreases in CD19+/CD5+ leukemic cells in five patients was noted as …

… programs have accelerated in several countries, many patients with CLL received a third
dose of vaccine. Results were extracted from eight studies meeting our criteria, providing data …

… T-cell function analysis in patients with CLL after multiple vaccination doses. The IFN-γ
and IL-2 responses were tested against the Miltenyi spike peptide pool. The mean number of …

… , the impact of repeated doses on antibody response is still unclear in these patients and, in
… in 42 CLL patients after two mRNA vaccine doses and subsequently the role of a third dose. …